Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 864,821 shares of CSTL stock, worth $23.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

864,821

Previous 809,934 6.78%

Holding current value

$23.8 Million

Previous $17.6 Million 39.88%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$17.4 - $31.47 $955,033 - $1.73 Million	54,887 Added 6.78%	864,821 $24.7 Million
Q2 2024 Aug 09, 2024	BUY	$18.84 - $24.94 $1.14 Million - $1.51 Million	60,675 Added 8.1%	809,934 $17.6 Million
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $1.54 Million - $2.16 Million	85,377 Added 12.86%	749,259 $16.6 Million
Q4 2023 Feb 07, 2024	BUY	$12.19 - $22.43 $1.32 Million - $2.43 Million	108,481 Added 19.53%	663,882 $14.3 Million
Q3 2023 Nov 09, 2023	BUY	$13.28 - $20.3 $874,063 - $1.34 Million	65,818 Added 13.44%	555,401 $9.38 Million
Q2 2023 Aug 09, 2023	BUY	$11.66 - $26.0 $69,155 - $154,206	5,931 Added 1.23%	489,583 $6.72 Million
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $3.11 Million - $4.56 Million	159,966 Added 49.42%	483,652 $11 Million
Q4 2022 Feb 09, 2023	BUY	$18.08 - $30.0 $1.54 Million - $2.56 Million	85,198 Added 35.72%	323,686 $7.62 Million
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $1.04 Million - $1.59 Million	46,410 Added 24.16%	238,488 $6.22 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $1.12 Million - $3.21 Million	69,700 Added 56.95%	192,078 $4.22 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $274,581 - $388,900	8,278 Added 7.26%	122,378 $5.49 Million
Q4 2021 Feb 09, 2022	BUY	$39.06 - $67.58 $2.34 Million - $4.04 Million	59,783 Added 110.06%	114,100 $4.89 Million
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $3.27 Million - $4.21 Million	54,317 New	54,317 $3.61 Million
Q2 2021 Aug 12, 2021	SELL	$50.07 - $76.78 $7.16 Million - $11 Million	-142,988 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $7.21 Million - $11.9 Million	122,306 Added 591.36%	142,988 $9.76 Million
Q4 2020 Feb 25, 2021	BUY	$43.6 - $73.05 $901,735 - $1.51 Million	20,682 New	20,682 $1.39 Million

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $724M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History